axitinib
Ligand Summary
A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
UNII: C9LVQ0YUXG
PubChem: 6450551
Guide to Pharmacology: 5659
ChEMBL: CHEMBL1289926
DrugCentral: 4225
LyCHI: C9S74HT6XVFD
Target Activities
48 Activities
Items per page:
1 – 10 of 48
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||